| | POLISH FINANCIAL SUPERVISION AUTHORITY | |
| |
| | | UNI - EN REPORT No | 21 | / | 2012 |
| | |
| | Date of issue: | 2012-03-07 | | | | | | | | |
| | Short name of the issuer | | | | | | | |
| | SOPHARMA AD | |
| | Subject | | | | | | | | | | |
| | Current report 21 buy back 2012 | |
| | Official market - legal basis | | | | | | |
| | Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne
| |
| | Unofficial market - legal basis | | | | | |
| | Contents of the report: | | | | | | | | |
| | ACQUISITION OF OWN SHARES
Current report No. 21/2012
Dated 07 March 2012
The Board of Directors of SOPHARMA AD (the “Company") hereby informs that from 01 March 2012 up to and including 07 March 2012 the Company bought 200 own shares representing 0.00015% of the share capital of the Company, to the total value of 570 BGN on the Bulgarian Stock Exchange. The average price per share was 2.85 BGN.
The shares have been bought on the basis of the general meeting resolution of 23.06.2010.
The intention of the Company is to use the repurchased shares in the future for the purpose of providing them to shareholders of companies targeted in mergers.
The total number of own shares after these transactions is 2520966, representing 1.910% of the share capital of the Company.
Legal grounds: Art. 56.1 of the Act on Public Offering, Conditions Governing the Introduction of Financial Instruments to Organized Trading, and Public Companies dated 29 July 2005.
Signatures of individuals authorized to represent the Company
Ognian Donev
| |
| | Annexes | | | | | | | | | | |
| | File | Description | |
| | Current report 21 buy back 2012.doc | Current report 21 buy back 2012 | |
